Skip to content
MedsAcross

Manufacturer

OWP Pharmaceuticals

Products listed
8
Molecules
2
Therapy areas
1

OWP Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 8 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
OWP Pharmaceuticals, Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply OWP Pharmaceuticals products through licensed channels, with the documents your regulator needs.

Neurology

8 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Levetiracetam 1000 mg tabletOralGeneric nameLevetiracetamUS FDAAvailable on request
Levetiracetam 750 mg tabletOralGeneric nameLevetiracetamUS FDAAvailable on request
Roweepra 250 mg tabletOralLevetiracetamUS FDAAvailable on request
Subvenite 10 mg/mL oral suspensionOralLamotrigineUS FDAAvailable on request
Subvenite 100 mg tabletOralLamotrigineUS FDAAvailable on request
Subvenite 150 mg tabletOralLamotrigineUS FDAAvailable on request
Subvenite 200 mg tabletOralLamotrigineUS FDAAvailable on request
Subvenite 25 mg tabletOralLamotrigineUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from OWP Pharmaceuticals

Send a request for any of these products. We confirm the licensed source, documents and lead time.